ABSTRACT
BACKGROUND: We present a case series of 10, atopic, African women who developed irritant contact dermatitis (ICD) from synthetic hair extensions. METHODS: Ten consecutive African female patients who presented with a pruritic cutaneous eruption on the neck over a period of 2 years are described. Patients underwent skin patch testing using both standard and hair commercial patch test panels and samples of their own hair extensions. Hair care products were not tested. RESULTS: All 10 patients used synthetic hair extensions. A strong history of atopy was documented for all the patients and examination was significant for eczematous, lichenified plaques at the location of contact with the free end of the hair extension. Patch test results yielded no relevant reactivity and a diagnosis of ICD was made for all patients. The lesions resolved completely on removal of the hair extensions and the use of topical steroids and emollients, dependent on eczema severity. CONCLUSIONS: Artificial hair extensions should be considered as a potential irritant, resulting in ICD. Patients with a history of atopy are at risk of developing ICD from synthetic hair extensions.
ABSTRACT
Subepidermal calcified nodules are lesions that primarily affect children and are most commonly located on the head. The current standard of treatment for these is surgical excision. However, surgical excision is not always possible and may not be cosmetically favorable. We describe the use of a CO2 laser as a successful treatment for a subepidermal calcified nodule of the finger.
Subject(s)
Calcinosis/surgery , Fingers/pathology , Laser Therapy/methods , Lasers, Gas/therapeutic use , Skin Diseases/surgery , Adolescent , Calcinosis/pathology , Female , Humans , Skin Diseases/pathologyABSTRACT
The American Academy of Dermatology has taken an active stance in addressing the lack of racial and ethnic diversity in the specialty. At the American Academy of Dermatology President's Conference on Diversity in Dermatology, which was held on August 5, 2017, key action items to increase the number of practicing board-certified dermatologists who are under-represented in medicine (UIM) were identified in 3 main areas. The action items include increasing the pipeline of UIM students applying to medical school, increasing UIM medical students' exposure to the field of dermatology and their level of interest in it, and increasing the number of UIM students recruited into dermatology residency programs.
Subject(s)
Cultural Diversity , Dermatology , Ethnicity , Racial Groups , Career Choice , Dermatology/education , Dermatology/statistics & numerical data , Female , Humans , Internship and Residency , Intersectoral Collaboration , Male , Mentors , Minority Groups , Societies, Medical , Students, Medical/statistics & numerical data , United StatesSubject(s)
Dermatology , Cross-Sectional Studies , Cultural Diversity , Ethnicity , Humans , Minority Groups , Retrospective Studies , United StatesABSTRACT
IMPORTANCE: Posttransplant lymphoproliferative disorder (PTLD) is an uncommon complication after solid organ transplants and hematopoietic stem cell transplants. Extranodal involvement in PTLD can involve several organ systems, including the central nervous system, bone marrow, lungs, gastrointestinal tract, and skin. Isolated involvement of the skin without systemic involvement in PTLD is rare. Primary cutaneous PTLD is generally categorized as either cutaneous T-cell lymphomas or cutaneous B-cell lymphomas, with variable Epstein-Barr virus (EBV) positivity. Herein, we describe an exceedingly uncommon case of a polymorphic variant of primary cutaneous PTLD. OBSERVATIONS: A woman in her 30s, who received an EBV+ deceased donor kidney transplant, presented with a 2-week history of 2 indurated patches over the lower abdomen. A skin biopsy revealed an atypical lymphoid proliferation with immunohistochemical stains demonstrating a mixed population of both B and T cells that stained strongly positive for EBV-encoded RNA. A bone marrow biopsy and positron emission tomography/computed tomography were negative for systemic involvement. The patient was treated with immunosuppression reduction and rituximab infusions. CONCLUSIONS AND RELEVANCE: This case highlights a rare polymorphic variant of primary cutaneous EBV-associated PTLD and increases awareness of this uncommon posttransplant complication. Cutaneous PTLD is reviewed, therefore dermatologists are aware of this uncommon disorder.
Subject(s)
Epstein-Barr Virus Infections/virology , Herpesvirus 4, Human/isolation & purification , Kidney Transplantation/adverse effects , Lymphoproliferative Disorders/virology , Skin Diseases, Viral/virology , Adult , Biopsy , Epstein-Barr Virus Infections/drug therapy , Epstein-Barr Virus Infections/immunology , Epstein-Barr Virus Infections/pathology , Female , Herpesvirus 4, Human/immunology , Humans , Immunohistochemistry , Immunologic Factors/therapeutic use , Immunosuppressive Agents/adverse effects , Lymphoproliferative Disorders/drug therapy , Lymphoproliferative Disorders/immunology , Lymphoproliferative Disorders/pathology , Positron-Emission Tomography , Rituximab/therapeutic use , Skin Diseases, Viral/drug therapy , Skin Diseases, Viral/immunology , Skin Diseases, Viral/pathology , Tomography, X-Ray Computed , Treatment OutcomeSubject(s)
Epidermal Cyst , Skin Diseases , Aged , Epidermal Cyst/metabolism , Epidermal Cyst/pathology , Humans , Male , Skin Diseases/metabolism , Skin Diseases/pathologyABSTRACT
Acute mucocutaneous methotrexate toxicity is not classically associated with prominent tissue eosinophilia. We present a case of acute methotrexate toxicity associated with pancytopenia and mucocutaneous erosion with interface dermatitis and numerous eosinophils. A 79-year-old male, with a history of psoriasis vulgaris on methotrexate therapy, presented with blisters of the oral mucosa, groin, sacrum, and extremities after daily consumption of methotrexate. Examination revealed blisters and erosions localized to psoriatic plaques, the perineum, and the oral mucosa. Laboratory evaluation demonstrated pancytopenia, megaloblastic anemia, and elevated liver function tests. A skin biopsy of an eroded plaque revealed psoriasiform epidermal hyperplasia with epidermal erosion, parakeratosis, and loss of the granular cell layer. There was an underlying band-like lymphoid infiltrate with interface dermatitis, dyskeratotic keratinocytes, and numerous eosinophils. Direct immunofluorescence studies were negative for the deposition of immunoreactants. Methotrexate was held, and the patient received leucovorin resulting in improvement of blood counts and cutaneous lesions. The histopathologic changes associated with acute mucocutaneous toxicity have been described as pauci-inflammatory erosions associated with dyskeratotic keratinocytes to interface dermatitis with necrotic keratinocytes and occasionally associated eosinophils. Although these changes are most often superimposed on psoriatic plaques, they have been reported to occur on normal skin. Therefore, the differential diagnosis may include lichen planus, a lichenoid drug eruption, or a fixed drug eruption, and given the presence of mucosal ulceration, incipient pemphigus vulgaris or paraneoplastic pemphigus vulgaris. This case illustrates that acute mucocutaneous methotrexate toxicity may be associated with both interface dermatitis and numerous eosinophils.
Subject(s)
Dermatologic Agents/adverse effects , Drug Eruptions/etiology , Eosinophilia/chemically induced , Methotrexate/adverse effects , Mouth Mucosa/drug effects , Psoriasis/drug therapy , Skin/drug effects , Aged , Biopsy , Diagnosis, Differential , Drug Eruptions/pathology , Eosinophilia/pathology , Humans , Male , Microscopy, Fluorescence , Mouth Mucosa/pathology , Pancytopenia/chemically induced , Predictive Value of Tests , Psoriasis/pathology , Skin/pathologyABSTRACT
While sunscreen is effective prevention for skin cancer, public sunscreen use and compliance are low. Identifying factors affecting sunscreen use and barriers to compliance are important to understand in order to increase sunscreen use, especially among high-risk individuals. We conducted a single institution survey of 429 dermatology clinic patients to better understand patients' barriers to sunscreen use. Overall several personal barriers to sunscreen use included dislike of feel or appearance of sunscreen (33.7%) and time constraints (15.3%). The cost was a barrier to use in 16.4% of cases underscoring the importance for dermatologists to consider socioeconomic barriers to sunscreen use and provide cost-effective sun protection counseling to patients whenever possible. Dermatologists recommending sunscreen use was associated with a higher rate of use of sunscreen (p < .001) highlighting the important role of sun protective counseling by the dermatologist.
Subject(s)
Patient Compliance , Skin Neoplasms/prevention & control , Sunscreening Agents/therapeutic use , Adult , Aged , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Sunburn/prevention & control , Surveys and QuestionnairesSubject(s)
Carcinoma, Basal Cell/surgery , Dermatologic Surgical Procedures/adverse effects , Skin Diseases, Vesiculobullous/pathology , Skin Neoplasms/surgery , Administration, Cutaneous , Adrenal Cortex Hormones/therapeutic use , Back , Biopsy, Needle , Carcinoma, Basal Cell/pathology , Dermatologic Surgical Procedures/methods , Follow-Up Studies , Humans , Immunohistochemistry , Male , Middle Aged , Postoperative Complications/drug therapy , Postoperative Complications/pathology , Risk Assessment , Severity of Illness Index , Skin Diseases, Vesiculobullous/drug therapy , Skin Diseases, Vesiculobullous/etiology , Skin Neoplasms/pathology , Treatment OutcomeABSTRACT
BACKGROUND: Little is currently known about health-related quality of life (HRQoL) of patients with cutaneous T-cell lymphoma (CTCL), a condition characterized by chronic, pruritic, visible lesions, features which may be uniquely influential. OBJECTIVE: The aim of this study was to establish baseline HRQoL data for patients with CTCL and identify its influencing factors. METHODS: Prospective, nonblinded survey design utilizing questionnaires including panels of QoL indices obtained from 105 patients with mycosis fungoides, Sezary syndrome, and CD30+ lymphoproliferative disorder. Chart review correlated QoL with year of disease onset/diagnosis, type/stage of disease, current/past therapies, and medical/psychiatric diagnoses. RESULTS: Psychiatric condition was significantly associated with symptoms (P < 0.01), emotions (P < 0.01), and functioning (P < 0.03) subscales along with overall composite measure (P < 0.01). High-grade systemic therapy (OR = 5.28) showed greater increase in odds of a lower health state than low grade (OR = 1.54). The number of medical comorbidities was significantly related to itching (P < 0.01). Increased age was a protective factor with respect to the emotions (P < 0.01), functioning (P < 0.01), and overall composite (P < 0.01) but not predictive of symptoms. Lower income was associated with higher bother on the symptoms subscale. CONCLUSIONS: HRQoL in CTCL appears related to a number of factors, including presence of a psychiatric condition, use of systemic (particularly high grade) therapy, number of medical comorbidities, and income.